TriSalus Life Sciences, Inc. announced a private placement that it has issued 6,167,776 shares of common stock, par value $0.0001 per share and 230,000 shares of common stock issuable upon conversion of shares of the Issuer?s Series A Convertible Preferred Stock on August 10, 2023. The transaction included participation from new investor, Frankenius Equity AB.